Difficulty: Medium
Average Score: 81%
Practice
In patients with Parkinson's disease, histologic studies suggest an imbalance in brain neurotransmitters. In contrast to normal individuals, the patients with Parkinson's disease have an abundance of which of the following neurons and associated neurotransmitters?
Correct answer
A
Rationale
The correct answer is A) Acetylcholine. In Parkinson's disease, there is a loss of dopaminergic neurons in the substantia nigra of the brain, leading to a decrease in dopamine levels. This dopamine deficiency results in an imbalance between dopamine and acetylcholine, causing an excess of acetylcholine activity in the basal ganglia. This imbalance contributes to the motor symptoms seen in Parkinson's disease, such as tremors, rigidity, and bradykinesia.
Option B) Dopamine is incorrect because, as mentioned earlier, Parkinson's disease is characterized by a lack of dopamine due to the degeneration of dopaminergic neurons.
Option C) Epinephrine and Option D) Norepinephrine are also incorrect as they are not primarily involved in the pathophysiology of Parkinson's disease. While norepinephrine plays a role in the sympathetic nervous system, it is not the neurotransmitter primarily affected in Parkinson's disease.
Understanding the neurotransmitter imbalance in Parkinson's disease is crucial for healthcare professionals to provide appropriate treatments such as dopamine replacement therapies or medications that target the acetylcholine-dopamine imbalance. This knowledge is also essential for nurses and other healthcare providers in educating patients and families about the disease process and rationale behind treatment strategies.
Option B) Dopamine is incorrect because, as mentioned earlier, Parkinson's disease is characterized by a lack of dopamine due to the degeneration of dopaminergic neurons.
Option C) Epinephrine and Option D) Norepinephrine are also incorrect as they are not primarily involved in the pathophysiology of Parkinson's disease. While norepinephrine plays a role in the sympathetic nervous system, it is not the neurotransmitter primarily affected in Parkinson's disease.
Understanding the neurotransmitter imbalance in Parkinson's disease is crucial for healthcare professionals to provide appropriate treatments such as dopamine replacement therapies or medications that target the acetylcholine-dopamine imbalance. This knowledge is also essential for nurses and other healthcare providers in educating patients and families about the disease process and rationale behind treatment strategies.